10/5/2026
Benuvia, Texas Ibogaine to produce ibogaine in U.S.
Partnership aims to manufacture pharmaceutical-grade ibogaine domestically.
Topic archive
texas ibogaine research corporation
9 stories
10/5/2026
Psyence BioMed to manufacture ibogaine in Texas with Benuvia
Psyence BioMed partners with Benuvia for U.S. ibogaine production, aiming to advance clinical research.
10/5/2026
Psyence BioMed partners with Benuvia for ibogaine production
Agreement aims to produce pharmaceutical-grade ibogaine in Texas facility.
9/28/2026
Psyence Biomedical secures $1.3M ibogaine licensing deal
Texas subsidiary gains exclusive U.S. rights to PsyLabs' ibogaine
9/28/2026
Psyence BioMed secures exclusive U.S. ibogaine license
Texas Ibogaine Research Corporation to lead U.S. ibogaine drug development.
9/28/2026
Psyence secures exclusive U.S. ibogaine license
Texas subsidiary gains rights to ibogaine hydrochloride for drug development.
9/23/2026
Psyence BioMed announces ibogaine investment and trial plans
Psyence BioMed to invest $5M in PsyLabs, plans Texas ibogaine trial.
9/23/2026
Psyence Biomedical expands with Texas ibogaine unit
Company invests $5 million in PsyLabs for ibogaine research and production.
9/14/2026
Psyence BioMed forms Texas entity for U.S. ibogaine research
Texas Ibogaine Research Corporation to spearhead U.S. ibogaine development efforts.